Hyperpolarized cardioplegic arrest with nicorandil: Advantages over other potassium channel openers

Circulation

Volumn 96, Issue 9 SUPPL., 1997, Pages

  Jayawant, A Mark ^a   Lawton, Jennifer S ^a   Hsia, Peng Wie ^a   Damiano Jr , Ralph J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Cardioplegia; Hyperpolarized arrest; Nicorandil; Potassium channel opener

Indexed keywords

APRIKALIM; CARDIOPLEGIC AGENT; GLIBENCLAMIDE; NICORANDIL; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; POTASSIUM CHLORIDE;

ANIMAL TISSUE; ARTICLE; CARDIOPLEGIA; CONTROLLED STUDY; DRUG EFFICACY; HEART ARREST; HEART LEFT VENTRICLE COMPLIANCE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPERPOLARIZATION; ISOLATED HEART; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; DIASTOLE; FEMALE; HEART; HEART ARREST, INDUCED; MALE; NIACINAMIDE; NICORANDIL; POTASSIUM CHANNELS; RABBITS; SYSTOLE;

EID: 0343052001     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kleber AG, Oetliker H. Cellular aspects of early contractile failure in ischemia. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven; 1992:1975-2020.
2. Reimer KA, Jennings RB. Myocardial ischemia, hypoxia, and infarction. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven; 1992:1973-1975.
3. Bolli R. Mechanism of myocardial stunning. Circulation. 1990;82: 723-728.
4. Marban E. Pathogenetic role for calcium in stunning? Cardiovasc Drugs Ther. 1991;5:891-895.
5. Gettes LS, Cascio WE. Effect of acute ischemia on cardiac electrophysiology. In: Fozzard HA, Haber E, Jennings RB, Katz AM, Morgan HE, eds. The Heart and Cardiovascular System. New York, NY: Raven; 1992:2021-2054.
6. Foglia RP, Steed DL, Follette DM, DeLand E, Buckberg GD. Iatrogenic myocardial edema with potassium cardioplegia. J Thorac Cardiovasc Surg. 1979;78:217-222.
7. Drewnowska K, Clemo HF, Baumgarten CM. Prevention of myocardial intracellular edema induced by St. Thomas' Hospital cardioplegic solution. J Mol Cell Cardiol. 1991;23:1215-1221.
8. Weng ZC, Nicolosi AC, Detwiler PW, Hsu DT, Schierman SW, Goldstein AH, Spotnitz HM. Effects of crystalloid, blood, and University of Wisconsin perfusates on weight, water content, and left ventricular compliance in the edema-prone, isolated heart model. J Thorac Cardiovasc Surg. 1992;103:504-513.
9. Gross GJ, Auchampach JA. Role of ATP dependent potassium channels in myocardial ischaemia. Cardiovasc Res. 1992;26: 1011-1016.
10. + channels in the heart. Pflugers Arch. 1989;414:593-598.
11. Cohen NM, Wise RM, Wechsler AS, Damiano RJ. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener. J Thorac Cardiovasc Surg. 1993;106: 317-328.
12. Maskal SL, Cohen NM, Hsia PW, Wechsler AW, Damiano RJ. Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim. J Thorac Cardiovasc Surg. 1995;110:1083-1095.
13. Lawton JS, Harrington GC, Allen CT, Hsia P, Damiano RJ. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg. 1996;61:1680-1688.
14. Taira N. Nicorandil as a hybrid between nitrates and potassium channel activators. Am J Cardiol. 1989;63:18J-24J.
15. Gross GJ, Auchampach JA, Maruyama M, Warltier DC, Pieper GM. Cardioprotective effects of nicorandil. J Cardiovasc Pharmacol. 1992;20(suppl III):S22-S28.
16. Sugimoto S, Puddu PE, Monti F, Schiariti M, Campa PP, Maino B. Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia. J Thorac Cardiovasc Surg. 1993;108:455-466.
17. Qiu Y, Galinanes M, Hearse DJ. Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia. J Thorac Cardiovasc Surg. 1995;110:1063-1072.
18. Menasche P, Kevelaitis E, Mouas C, Grousset C, Piwnica A, Bloch G. Preconditioning with potassium channel openers: a new concept for enhancing cardioplegic protection? J Thorac Cardiovasc Surg. 1995;110:1606-1614.
19. + cardioplegia. Int J Cardiol. 1995;48:11-25.
20. Grover G, Sleph P, Parham C. Nicorandil improves postischemic contractile function independently of direct myocardial effects. J Cardiovasc Pharmacol. 1990;15:698-705.
21. Moon M, DeAnda A, Daughters G, Ingels N, Miller D. Experimental evaluation of different chordal preservation methods during mitral valve replacement. Ann Thorac Surg. 1994;58:931-944.
22. Shintani H, Glatz S. Effect of disrupting the mitral apparatus on left ventricular function in dogs. Circulation. 1993;87:2001-2015.
23. Fremes S, Zhang J, Furukawa R, Mickle D, Weisel R. Adenosine pretreatment for prolonged cardiac storage. J Thorac Cardiovasc Surg. 1995;110:293-301.
24. Katz AM. The cardiac action potential. In: Katz AM, ed. Physiology of the Heart. New York, NY: Raven; 1992:438-472.
25. Frydman A. Pharmacokinetic profile of nicorandil in humans: an overview. J Cardiovasc Pharmacol. 1992;20(suppl III):S34-S44.
26. Hsu DT, Weng ZC, Nicolosi AC, Detwiler PW, Sciacca R, Spotnitz HM. Quantitative effects of myocardial edema on the left ventricular pressure-volume relation. J Thorac Cardiovasc Surg. 1993;106: 651-657.
27. Cohen NM, Allen CA, Belz MK, Nixon TE, Wise RM, Damiano RJ Jr. Electrophysiological consequences of hypothermic hyperkalemic elective cardiac arrest. J Card Surg. 1993;8:156-160.
28. Cohen NM, Allen CA, Hsia P, Nixon TE, Wise RM, Damiano RJ Jr. Electrophysiologic consequences of hyperkalemic cardioplegia during surgical ischemia. Ann Thorac Surg. 1994;57:1076-1083.
29. Katz AM. Cardiac mechanics. In: Katz AM, ed. Physiology of the Heart. New York, NY: Raven; 1992:217-233.
30. Hearse DJ, Baimbridge MV, Jynge P. Basic concepts. In: Hearse DJ, Baimbridge MV, Jynge P, eds. Protection of the Ischemic Myocardium: Cardioplegia. New York, NY: Raven; 1981:151-166.
31. Maskal SL, Fields CE, Cohen NM, Damiano RJ. Persistent electrical activity during hyperpolarized cardiac arrest does not affect post ischemic myocardial recovery. Surg Forum. 1995;46:222-224.
32. Klocke FJ, Braunwald E, Ross J. Oxygen cost of electrical activity of the heart. Circ Res. 1966;18:357-365.
33. Galinanes M, Shattock MJ, Hearse DJ. Effects of potassium channel modulation during global ischemia in isolated rat heart with and without cardioplegia. Cardiovasc Res. 1992;26: 1063-1068.
34. D'Alonzo AJ, Darbenzio RB, Parham CS, Grover G. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc Res. 1992;26:1046-1053.
35. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation. 1994;89:1769-1775.